drugset / Trial / NCT02823028
Twitter-enabled Mobile Messaging for Smoking Relapse Prevention (Tweet2Quit)
Phase 2
Completed
980 enrolled
University of California, Irvine
National Cancer Institute (NCI) · collabStanford University · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
Tweet2Quit is an innovative smoking cessation intervention that combines real-time online peer-to-peer support with auto messaging. In a three-group randomized controlled trial, the investigators will compare: 1) usual care, 2) Tweet2Quit-coed, and 3) Tweet2Quit-Women only.
Timeline
- Start
- 2016-10
- Primary completion
- 2022-09
- Completion
- 2022-09
Publications
- Pechmann C, Phillips C, Calder D, Prochaska JJ. Facebook Recruitment Using Zip Codes to Improve Diversity in Health Research: Longitudinal Observational Study. J Med Internet Res. 2020 Jun 5;22(6):e17554. doi: 10.2196/17554.
- Pechmann CA, Calder D, Phillips C, Delucchi K, Prochaska JJ. The Use of Web-Based Support Groups Versus Usual Quit-Smoking Care for Men and Women Aged 21-59 Years: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2020 Jan 14;9(1):e16417. doi: 10.2196/16417.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Nicotine | Unknown | — | — |
Indications
No indication recorded.